SGMO icon

Sangamo Therapeutics

118 hedge funds and large institutions have $241M invested in Sangamo Therapeutics in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
-8
Holders Change %
-6.35%
% of All Funds
2.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
20
Increased
29
Reduced
40
Closed
22
Calls
$3.91M
Puts
$2.49M
Net Calls
+$1.42M
Net Calls Change
-$669K
Name Holding Trade Value Shares
Change
Shares
Change %
SM
126
Sabby Management
Florida
-$193K -63,204 Closed
Russell Investments Group
127
Russell Investments Group
United Kingdom
-$179K -58,739 Closed
ARTA
128
A.R.T. Advisors
New York
-$161K -53,046 Closed
PCMI
129
Princeton Capital Management Inc
New Jersey
-$135K -44,250 Closed
Squarepoint
130
Squarepoint
New York
-$119K -39,001 Closed
PP
131
Paloma Partners
Connecticut
-$67K -22,011 Closed
TSS
132
Two Sigma Securities
New York
-$66K -21,733 Closed
TCM
133
Teza Capital Management
Illinois
-$37K -11,987 Closed
HSBC Holdings
134
HSBC Holdings
United Kingdom
-$36K -11,961 Closed
Two Sigma Advisers
135
Two Sigma Advisers
New York
-$36K -11,800 Closed
PAM
136
Premier Asset Management
Illinois
-$30K -10,000 Closed
PA
137
Perceptive Advisors
New York
-$1K -272 Closed
TFA
138
Transamerica Financial Advisors
Florida
-$1K -117 Closed